LOW-MOLECULAR DNA FROM STURGEON MILT, A METHOD OF OBTAINING THE DNA AND A PHARMACEUTICAL PREPARATION BASED ON IT

The present invention relates to low-molecular DNA obtained from sturgeon milt and a pharmaceutical preparation based on it. Also proposed is a method of obtaining the said low-molecular DNA from sturgeon milt. Disclosed is the use of the new preparation based on the low-molecular DNA as a haemocorr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SIMONOVA, LIDIA VASILIEVNA, KOROLEVA, NELLI BORISOVNA, TARASOVA, LARISA ALEXANDROVNA, KOCHETKOVA, MARINA GAVRILOVNA, TRESCHALINA, ELENA MIKKAILOVNA, ZOBOVA, OLGA BORISOVNA, KONAREV, ALEXANDR ANDREEVICH, KARPOV, IGOR NIKOLAEVICH, DURNOV, LEV ABRAMOVICH, KIRAKOSIAN, STEPAN VAZGENOVICH, SIMONOVA, LJUDMILA VASILIEVNA, KAZAROVA, IRINA LAZAREVNA, ASAFOV, ALEXANDR VILENOVICH, BEZJULEV, VYACHESLAV VLADIMIROVICH, TRESCHALIN, IVAN DMITRIEVICH, BODYAGIN, DMITRY ALEXANDROVICH, ANOSOVA, INDIA GRIGORIEVNA, SYRKIN, ANATOLY BORISOVICH, PEREVERZEVA, ELEONORA RAFAILOVNA, SUSULEVA, NATALYA ALEXANDROVNA, ILYASHENKO, VIKTOR VLADIMIROVICH
Format: Patent
Sprache:eng ; fre ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to low-molecular DNA obtained from sturgeon milt and a pharmaceutical preparation based on it. Also proposed is a method of obtaining the said low-molecular DNA from sturgeon milt. Disclosed is the use of the new preparation based on the low-molecular DNA as a haemocorrector and inhibitor of viral activity, in particular HIV infections and mucous membrane diseases of various etiologies. Also disclosed is the use of the low-molecular DNA as a universal cosmetic additive. L'invention concerne de l'ADN de faible masse moléculaire obtenue à partir de laitance d'esturgeon ainsi qu'une préparation pharmaceutique à base de celui-ci. L'invention concerne également un procédé d'obtention dudit ADN de faible masse moléculaire à partir de laitance d'esturgeon. De plus, l'invention concerne l'utilisation de la nouvelle préparation à base de l'ADN de faible masse moléculaire comme hémocorrecteur et inhibiteur d'activité virale, notamment d'infections à VIH et de maladies de la muqueuse de diverses étiologies. En outre, l'invention concerne l'utilisation de l'ADN de faible masse moléculaire comme additif cosmétique universel.